BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 27288676)

  • 1. The treatment of behavioral disturbances and psychosis associated with dementia.
    Lochhead JD; Nelson MA; Maguire GA
    Psychiatr Pol; 2016; 50(2):311-22. PubMed ID: 27288676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.
    Kindermann SS; Dolder CR; Bailey A; Katz IR; Jeste DV
    Drugs Aging; 2002; 19(4):257-76. PubMed ID: 12038878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia update. Pharmacologic management of agitation and psychosis in older demented patients.
    Zaraa AS
    Geriatrics; 2003 Oct; 58(10):48-50, 52-3. PubMed ID: 14569642
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.
    Aupperle P
    Am J Alzheimers Dis Other Demen; 2006; 21(2):101-8. PubMed ID: 16634465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of antipsychotics in dementia depended on the definition of patients and outcomes: a meta-epidemiological study.
    Smeets CHW; Zuidema SU; Hulshof TA; Smalbrugge M; Gerritsen DL; Koopmans RTCM; Luijendijk HJ
    J Clin Epidemiol; 2018 Sep; 101():17-27. PubMed ID: 29782995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agitation. How to manage behavior disturbances in the older patient with dementia.
    Neugroschl J
    Geriatrics; 2002 Apr; 57(4):33-7; quiz 40. PubMed ID: 11974389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.
    Raskind MA; Wang LY
    Int Psychogeriatr; 2014 Jun; 26(6):879-83. PubMed ID: 24703502
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment strategies for agitation and psychosis in dementia.
    Tariot PN
    J Clin Psychiatry; 1996; 57 Suppl 14():21-9. PubMed ID: 9024333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of psychosis and depression to behavioral disturbances in geropsychiatric inpatients with dementia.
    Kunik ME; Snow-Turek AL; Iqbal N; Molinari VA; Orengo CA; Workman RH; Yudofsky SC
    J Gerontol A Biol Sci Med Sci; 1999 Mar; 54(3):M157-61. PubMed ID: 10191845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methodological and regulatory features of clinical trials for behavioral and psychological symptoms in the course of dementia].
    Diana G
    Ann Ist Super Sanita; 2003; 39(2):267-74. PubMed ID: 14587227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone for the treatment of behavioral disturbances in dementia: a case series.
    Herrmann N; Rivard MF; Flynn M; Ward C; Rabheru K; Campbell B
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):220-3. PubMed ID: 9608413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus.
    Kales HC; Lyketsos CG; Miller EM; Ballard C
    Int Psychogeriatr; 2019 Jan; 31(1):83-90. PubMed ID: 30068400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Kurlan R; Cummings J; Raman R; Thal L;
    Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes.
    Mueller C; John C; Perera G; Aarsland D; Ballard C; Stewart R
    Eur J Epidemiol; 2021 Jan; 36(1):89-101. PubMed ID: 32415541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
    Lawlor BA
    J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approach to managing behavioural disturbances in dementia.
    Omelan C
    Can Fam Physician; 2006 Feb; 52(2):191-9. PubMed ID: 16529392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressants for agitation and psychosis in patients with dementia.
    Bui Q
    Am Fam Physician; 2012 Jan; 85(1):20-2. PubMed ID: 22230303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.